212 related articles for article (PubMed ID: 23020176)
1. Comparison of the 2002 and 2010 TNM classification systems regarding outcome prediction in clear cell and papillary renal cell carcinoma.
Pichler M; Hutterer GC; Chromecki TF; Jesche J; Kampel-Kettner K; Groselj-Strele A; Hoefler G; Pummer K; Zigeuner R
Histopathology; 2013 Jan; 62(2):237-46. PubMed ID: 23020176
[TBL] [Abstract][Full Text] [Related]
2. Predictive ability of the 2002 and 2010 versions of the Tumour-Node-Metastasis classification system regarding metastasis-free, cancer-specific and overall survival in a European renal cell carcinoma single-centre series.
Pichler M; Hutterer GC; Chromecki TF; Jesche J; Kampel-Kettner K; Groselj-Strele A; Pummer K; Zigeuner R
BJU Int; 2013 Apr; 111(4 Pt B):E191-5. PubMed ID: 23107473
[TBL] [Abstract][Full Text] [Related]
3. Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort.
Frank I; Blute ML; Leibovich BC; Cheville JC; Lohse CM; Zincke H
J Urol; 2005 Jun; 173(6):1889-92. PubMed ID: 15879769
[TBL] [Abstract][Full Text] [Related]
4. Impact of several histopathological prognosticators and local tumour extension on oncological outcome in pT3b/c N0M0 renal cell carcinoma.
Roos FC; Weirich J; Victor A; Elsässer A; Brenner W; Biesterfeld S; Hampel C; Thüroff JW
BJU Int; 2009 Aug; 104(4):461-9. PubMed ID: 19338563
[TBL] [Abstract][Full Text] [Related]
5. Presence and extent of histological tumour necrosis is an adverse prognostic factor in papillary type 1 but not in papillary type 2 renal cell carcinoma.
Pichler M; Hutterer GC; Chromecki TF; Pummer K; Mannweiler S; Zigeuner R
Histopathology; 2013 Jan; 62(2):219-28. PubMed ID: 22957986
[TBL] [Abstract][Full Text] [Related]
6. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.
Dimarco DS; Lohse CM; Zincke H; Cheville JC; Blute ML
Urology; 2004 Sep; 64(3):462-7. PubMed ID: 15351571
[TBL] [Abstract][Full Text] [Related]
7. Reclassification of the current tumor, node, metastasis staging in pT3 renal cell carcinoma.
Fujita T; Iwamura M; Yanagisawa N; Muramoto M; Okayasu I; Baba S
Int J Urol; 2008 Jul; 15(7):582-6. PubMed ID: 18479355
[TBL] [Abstract][Full Text] [Related]
8. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
Zigeuner R; Hutterer G; Chromecki T; Imamovic A; Kampel-Kettner K; Rehak P; Langner C; Pummer K
Eur Urol; 2010 Jan; 57(1):102-9. PubMed ID: 19062157
[TBL] [Abstract][Full Text] [Related]
9. Multiinstitutional European validation of the 2002 TNM staging system in conventional and papillary localized renal cell carcinoma.
Ficarra V; Schips L; Guillè F; Li G; De La Taille A; Prayer Galetti T; Cindolo L; Novara G; Zigeuner RE; Bratti E; Tostain J; Altieri V; Abbou CC; Artibani W; Patard JJ
Cancer; 2005 Sep; 104(5):968-74. PubMed ID: 16007683
[TBL] [Abstract][Full Text] [Related]
10. Application of TNM, 2002 version, in localized renal cell carcinoma: is it able to predict different cancer-specific survival probability?
Ficarra V; Novara G; Galfano A; Novella G; Schiavone D; Artibani W
Urology; 2004 Jun; 63(6):1050-4. PubMed ID: 15183948
[TBL] [Abstract][Full Text] [Related]
11. Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors.
Moch H; Gasser T; Amin MB; Torhorst J; Sauter G; Mihatsch MJ
Cancer; 2000 Aug; 89(3):604-14. PubMed ID: 10931460
[TBL] [Abstract][Full Text] [Related]
12. Histologic tumor necrosis is an independent prognostic indicator for clear cell and papillary renal cell carcinoma.
Pichler M; Hutterer GC; Chromecki TF; Jesche J; Kampel-Kettner K; Rehak P; Pummer K; Zigeuner R
Am J Clin Pathol; 2012 Feb; 137(2):283-9. PubMed ID: 22261455
[TBL] [Abstract][Full Text] [Related]
13. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
14. Proposal for reclassification of the TNM staging system in patients with locally advanced (pT3-4) renal cell carcinoma according to the cancer-related outcome.
Ficarra V; Novara G; Iafrate M; Cappellaro L; Bratti E; Zattoni F; Artibani W
Eur Urol; 2007 Mar; 51(3):722-9; discussion 729-31. PubMed ID: 16904819
[TBL] [Abstract][Full Text] [Related]
15. Simple enucleation versus radical nephrectomy in the treatment of pT1a and pT1b renal cell carcinoma.
Minervini A; Serni S; Tuccio A; Siena G; Vittori G; Masieri L; Giancane S; Lanciotti M; Khorrami S; Lapini A; Carini M
Ann Surg Oncol; 2012 Feb; 19(2):694-700. PubMed ID: 21861225
[TBL] [Abstract][Full Text] [Related]
16. pT1 substaging in renal cell carcinoma: validation of the 2002 TNM staging modification of malignant renal epithelial tumors.
Salama ME; Guru K; Stricker H; Peterson E; Peabody J; Menon M; Amin MB; De Peralta-Venturina M
J Urol; 2005 May; 173(5):1492-5. PubMed ID: 15821466
[TBL] [Abstract][Full Text] [Related]
17. A novel grading system for clear cell renal cell carcinoma incorporating tumor necrosis.
Delahunt B; McKenney JK; Lohse CM; Leibovich BC; Thompson RH; Boorjian SA; Cheville JC
Am J Surg Pathol; 2013 Mar; 37(3):311-22. PubMed ID: 23348209
[TBL] [Abstract][Full Text] [Related]
18. Morphological subtyping of papillary renal cell carcinoma: clinicopathological characteristics and prognosis.
Yamashita S; Ioritani N; Oikawa K; Aizawa M; Endoh M; Arai Y
Int J Urol; 2007 Aug; 14(8):679-83. PubMed ID: 17681054
[TBL] [Abstract][Full Text] [Related]
19. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients.
Gudbjartsson T; Hardarson S; Petursdottir V; Thoroddsen A; Magnusson J; Einarsson GV
Eur Urol; 2005 Oct; 48(4):593-600. PubMed ID: 15964127
[TBL] [Abstract][Full Text] [Related]
20. Translocation renal cell carcinoma: lack of negative impact due to lymph node spread.
Geller JI; Argani P; Adeniran A; Hampton E; De Marzo A; Hicks J; Collins MH
Cancer; 2008 Apr; 112(7):1607-16. PubMed ID: 18278810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]